ALNY vs UTHR · P/E 76, rev $1.29B vs P/E 20, rev $1.56B
Alnylam Pharmaceuticals Inc (ALNY) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the ALNY and UTHR stock pages for the full models.
Not investment advice.